|
|
|
Insider
Information: |
Higgins John L |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,806,928 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$48,561,124 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
2,806,928 |
|
|
Total
Value |
$48,561,124 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
11
|
Stock
price went up :
|
0
|
5
|
Stock
price went down : |
0
|
6
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-38.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
165 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2018-01-19 |
4 |
AS |
$151.92 |
$4,318,902 |
D/D |
(28,099) |
134,200 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
President & CEO |
|
2015-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
15,945 |
136,044 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2019-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
12,809 |
138,899 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-03-20 |
4 |
AS |
$109.10 |
$436,400 |
D/D |
(4,000) |
139,171 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-06-09 |
4 |
AS |
$114.87 |
$1,378,440 |
D/D |
(12,000) |
139,171 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-06-21 |
4 |
AS |
$120.00 |
$559,920 |
D/D |
(4,666) |
139,171 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-08-08 |
4 |
AS |
$125.00 |
$685,375 |
D/D |
(5,483) |
139,171 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-09-05 |
4 |
AS |
$130.00 |
$650,000 |
D/D |
(5,000) |
139,171 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-11-17 |
4 |
S |
$140.34 |
$316,888 |
D/D |
(2,258) |
141,284 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2019-03-13 |
4 |
B |
$114.29 |
$285,725 |
D/D |
2,500 |
141,399 |
2.81 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-03-08 |
4 |
D |
$106.92 |
$157,493 |
D/D |
(1,473) |
143,171 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-11-16 |
4 |
S |
$142.53 |
$750,991 |
D/D |
(5,269) |
143,542 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-06-21 |
4 |
OE |
$21.00 |
$97,986 |
D/D |
4,666 |
143,837 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2019-05-14 |
4 |
B |
$113.50 |
$283,750 |
D/D |
2,500 |
143,899 |
2.81 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-09-05 |
4 |
OE |
$21.00 |
$105,000 |
D/D |
5,000 |
144,171 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-03-08 |
4 |
OE |
$10.05 |
$157,534 |
D/D |
15,675 |
144,644 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-08-08 |
4 |
OE |
$21.00 |
$115,143 |
D/D |
5,483 |
144,654 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2019-05-31 |
4 |
B |
$108.20 |
$108,202 |
D/D |
1,000 |
144,899 |
2.81 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-12-28 |
4 |
D |
$138.66 |
$720,893 |
D/D |
(5,199) |
146,050 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2019-07-31 |
4 |
B |
$95.45 |
$176,583 |
D/D |
1,850 |
146,749 |
2.81 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-10-13 |
4 |
D |
$143.04 |
$249,462 |
D/D |
(1,744) |
148,811 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
CEO & President |
|
2007-02-01 |
4 |
A |
$12.68 |
$1,902,000 |
D/D |
150,000 |
150,000 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-10-13 |
4 |
OE |
$21.92 |
$249,537 |
D/D |
11,384 |
150,555 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-06-09 |
4 |
OE |
$21.00 |
$252,000 |
D/D |
12,000 |
151,171 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-12-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,965 |
151,249 |
0 |
- |
|
165 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|